临床试验不良事件监管在可手术III期非小细胞肺癌新辅助治疗中的作用

BACKGROUND AND OBJECTIVE: Programmed cell death protein 1 (PD-1) combined with platinum containing dual drug chemotherapy is a new adjuvant treatment option for operable stage III non-small cell lung cancer (NSCLC), and the quality assurance of clinical trials of related drugs plays a crucial role i...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, Yun, ZHOU, Shuang, TAO, Wentao, LI, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365963/
https://www.ncbi.nlm.nih.gov/pubmed/37488083
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.23

Ejemplares similares

Ejemplares similares